Zeria Pharmaceutical Co., Ltd.
Research Zeria Pharmaceutical Co., Ltd. (4559.T) on Bullrun: market cap JPY 88.51B, P/E 10.8, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4559.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 88.51B
- P/E10.8
- Dividend yield2.5%
- Financial periodFY2026
- RevenueJPY 89.16B
- Revenue growth2.1%
- Net incomeJPY 8.45B
- Free cash flowJPY 7.06B
- Gross margin73.1%
Valuation Snapshot
latest market cap is JPY 88.51B; P/E is 10.8; dividend yield is 2.5%.
Peer valuation comparison
Latest P/E is 10.76x versus a Healthcare sector median of 21.69x (50.4% below).
Latest dividend yield is 2.48% versus a Healthcare sector median of 2.41% (2.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 89.16B | JPY 8.45B | JPY 7.06B | 73.1% | 191.8 | JPY 27.76B | JPY 39.10B | JPY 108.40B |
| FY2025 | JPY 87.31B | JPY 9.94B | JPY 10.19B | 73.3% | 225.42 | JPY 23.59B | JPY 41.16B | JPY 89.54B |
| FY2024 | JPY 75.73B | JPY 7.73B | JPY 8.28B | 73.3% | 175.39 | JPY 20.32B | JPY 46.23B | JPY 79.62B |
| FY2023 | JPY 68.38B | JPY 6.20B | JPY 10.50B | 72.4% | 140.26 | JPY 16.22B | JPY 49.43B | JPY 65.45B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 88.51B | 10.8 | 2.5% | 50 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 50 JPY, yield 2.5%.
| Year | Dividends/share |
|---|---|
| FY2026 | 50 JPY |
| FY2025 | 48 JPY |
| FY2024 | 45 JPY |
| FY2023 | 44 JPY |
| FY2022 | 36 JPY |
About Zeria Pharmaceutical Co., Ltd.
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zeria Pharmaceutical Co., Ltd.'s market cap?
Zeria Pharmaceutical Co., Ltd.'s market capitalization is JPY 88.51B.
What is Zeria Pharmaceutical Co., Ltd.'s P/E ratio?
Zeria Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 10.8.
Does Zeria Pharmaceutical Co., Ltd. pay a dividend?
Zeria Pharmaceutical Co., Ltd. has a dividend yield of 2.5%.
What does Zeria Pharmaceutical Co., Ltd. do?
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments.